IndraLab

Statements


USP12 deubiquitinates MDM2. 2 / 2
1 | 1

reach
"We find that USP12 deubiquitinates MDM2 and AR, which in turn controls the levels of the TP53 tumour suppressor and AR oncogene in prostate cancer."

"We find that <span class="match term0">USP12</span> deubiquitinates <span class="match term1">MDM2</span> and AR, which in turn controls the levels of the TP53 tumour suppressor and AR oncogene in prostate cancer."